IL27 and posterior cortical atrophy: These findings indicate the potential of IL-27 and cabo in not only reducing tumor burden but also in improving bone quality by modulating bone cell differentiation and factors affecting the bone-tumor interface, a crucial aspect in the management of bone-metastatic PCa.